Pharmasyntez has received a loan for the construction of the production of anticancer drugs

VTB Bank issued the “Pharmasyntez” a loan of 2 billion rubles for the construction of a plant for the production of anticancer drugs in St. Petersburg. About it reports TASS.

As explained in the Bank, financing is carried out in the framework of the Ministry of industry and trade, aimed at supporting increasing the volume of production and sales competitiveness of Russian industrial products. The size of the subsidy interest rate is 4.5% per annum.

Currently, the “pharmasyntez-Nord” implements the investment project for the construction of the second phase of a pharmaceutical plant anticancer drugs. The investment project aimed at further reducing the share of import medicines in the Russian market. The production of the plant is planned to be realized not only in Russia but in the CIS countries and far abroad.

Earlier VTB has financed the construction of the first plant “Parasites-Nord” on the territory of the SEZ. The total investment in the project will amount to 3 billion rubles. Start of production is scheduled for the first half of 2021.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]